INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Van Hulzen Asset Management, LLC's Holding History (CIK: 0001600145)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 4,600 Value ($000) $607 Avg Close Range
Q4 2024
Shares 5,000 Value ($000) $418 Avg Close Range
Q3 2024
Shares 5,000 Value ($000) $0 Avg Close Range
Q2 2024
Shares 5,300 Value ($000) $0 Avg Close Range
Q1 2024
Shares 5,300 Value ($000) $0 Avg Close Range
Q4 2023
Shares 5,700 Value ($000) $0 Avg Close Range
Q3 2023
Shares 6,000 Value ($000) $0 Avg Close Range
Q2 2023
Shares 6,000 Value ($000) $0 Avg Close Range
Q1 2023
Shares 6,400 Value ($000) $0 Avg Close Range
Q4 2022
Shares 6,400 Value ($000) $0 Avg Close Range
Q3 2022
Shares 6,400 Value ($000) $298 Avg Close Range
Q2 2022
Shares 6,400 Value ($000) $365 Avg Close Range
Q1 2022
Shares 6,600 Value ($000) $404 Avg Close Range
Q4 2021
Shares 7,100 Value ($000) $372 Avg Close Range
Q3 2021
Shares 7,100 Value ($000) $265 Avg Close Range
Q2 2021
Shares 9,000 Value ($000) $367 Avg Close Range
Q1 2021
Shares 9,800 Value ($000) $333 Avg Close Range
Q4 2020
Shares 11,000 Value ($000) $350 Avg Close Range
Q3 2020
Shares 10,800 Value ($000) $277 Avg Close Range
Q2 2020
Shares 10,600 Value ($000) $272 Avg Close Range